ArticleBMC cancer2021

Study protocol of the LARK (TROG 17.03) clinical trial: a phase II trial investigating the dosimetric impact of Liver Ablative Radiotherapy using Kilovoltage intrafraction monitoring.

Yoo Young Dominique Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.